Moors & Cabot’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,788
Closed -$300K 726
2019
Q3
$300K Buy
1,788
+107
+6% +$17.4K 0.03% 445
2019
Q2
$280K Sell
1,681
-9,053
-84% -$1.25M 0.04% 427
2019
Q1
$1.58M Buy
10,734
+2,491
+30% +$361K 0.21% 118
2018
Q4
$1.1M Sell
8,243
-3,238
-28% -$531K 0.17% 143
2018
Q3
$2.19M Sell
11,481
-549
-5% -$101K 0.27% 96
2018
Q2
$2.01M Buy
12,030
+67
+0.6% +$10.8K 0.27% 99
2018
Q1
$2.01M Buy
11,963
+2,998
+33% +$503K 0.27% 96
2017
Q4
$1.46M Sell
8,965
-3,235
-27% -$581K 0.19% 127
2017
Q3
$2.48M Buy
12,200
+8,690
+248% +$2.02M 0.36% 77
2017
Q2
$846K Sell
3,510
-94
-3% -$22.1K 0.14% 185
2017
Q1
$864K Sell
3,604
-11
-0.3% -$2.56K 0.15% 177
2016
Q4
$769K Sell
3,615
-265
-7% -$54.9K 0.13% 196
2016
Q3
$899K Buy
3,880
+575
+17% +$141K 0.15% 163
2016
Q2
$765K Buy
3,305
+111
+3% +$25.6K 0.13% 191
2016
Q1
$855K Sell
3,194
-304
-9% -$87K 0.15% 168
2015
Q4
$1.09M Buy
3,498
+2,095
+149% +$624K 0.2% 138
2015
Q3
$381K Buy
1,403
+258
+23% +$79.3K 0.07% 304
2015
Q2
$348K Buy
1,145
+59
+5% +$17.6K 0.06% 351
2015
Q1
$323K Buy
+1,086
New +$310K 0.05% 362

Other funds holding AGN

Moors & Cabot's AGN Position: Q4 2019 in Review

Moors & Cabot sold out of Allergan plc (AGN) in Q4 2019, closing a stake of 1,788 shares — an estimated $300K sold.

Moors & Cabot first reported a position in AGN in Q1 2015 and held it in 19 quarters. The position peaked at $2.48M in Q3 2017. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.

  • Moors & Cabot reported no remaining Allergan plc position as of Q4 2019 after selling out during the quarter.
  • Moors & Cabot sold 1,788 Allergan plc shares in Q4 2019, an estimated $300K.
  • Moors & Cabot first reported a position in Allergan plc in Q1 2015 and held it in 19 quarters.
  • Moors & Cabot's Allergan plc position peaked at $2.48M in Q3 2017.
  • 957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.

Based on Moors & Cabot's 13F filing for Q4 2019, filed 28 Jan 2020.